nifedipine has been researched along with mibefradil in 78 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (23.08) | 18.2507 |
2000's | 35 (44.87) | 29.6817 |
2010's | 23 (29.49) | 24.3611 |
2020's | 2 (2.56) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Keserü, GM | 1 |
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Jia, L; Sun, H | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Cho, YS; Hwang, EM; Jung, SY; Lim, SM; Min, SJ; Pae, AN; Park, KD; Viswanath, AN | 1 |
Clozel, JP; Hess, P; Véniant, M; Wolfgang, R | 1 |
Himori, N; Sato, Y; Watanabe, H | 1 |
Archambault, F; Dalle Ave, S; Lacourcière, Y; Lefebvre, J; Lindberg, E; Poirier, L; Ward, C | 1 |
Böhm, M; Cremers, B; Flesch, M; Südkamp, M | 1 |
Nakagawa, M; Sasaki, S | 1 |
Kobrin, I; Lacourcière, Y; Massie, BM; Viskoper, R; Woittiez, A | 1 |
Charlon, V; Kobrin, I; Lindberg, E; Pordy, R | 1 |
Pitt, B | 1 |
Kobrin, I | 1 |
Conlin, PR; Williams, GH | 1 |
Bailey, R; Huysmans, FT; Kobrin, I; Mion Júnior, D; Robson, RA; Villa, G; Woittiez, AJ | 1 |
Koen, R; Lacolley, P; Levy, BI; Poitevin, P | 1 |
Brixius, K; Hoischen, S; Mohr, V; Müller-Ehmsen, J; Münch, G; Schwinger, RH | 1 |
Pordy, R; Woittiez, A | 1 |
Fagard, R; Lijnen, P; Petrov, V | 2 |
Lijnen, P; Petrov, V | 1 |
Martini, M; Rispoli, G; Rossi, ML; Rubbini, G | 1 |
Ceric, F; Kerr, B; Kong, M; Morales, P; Pizarro, E; Vigil, P | 1 |
Protas, L; Robinson, RB | 1 |
Han, CT; Lee, JH; Son, WY | 1 |
Duggan, JA; Tabrizchi, R | 2 |
Hill, MA; Kotecha, N; Murphy, TV; Potocnik, SJ | 1 |
Esler, MD; Kamen, PW; Krum, H; Lim, S; Pellizzer, AM | 1 |
Darné, B; Démolis, JL; Funck-Brentano, C; Jaillon, P; Ragueneau, I; Sao, AB | 1 |
Himmel, HM; Ravens, U; Stengel, W | 1 |
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Tokuyama, H | 1 |
Fujiwara, K; Hayashi, K; Nagahama, T; Ozawa, Y; Saruta, T | 1 |
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tokuyama, H | 1 |
Asokan, KT; Mishra, SK; Raviprakash, V; Sarkar, SN | 1 |
Anderson, UA; Bradley, JE; Hollywood, MA; McHale, NG; Thornbury, KD; Woolsey, SM | 1 |
Holstein-Rathlou, NH; Jensen, BL; Jensen, LJ; Salomonsson, M | 1 |
Al-Mehdi, AB; Chatterjee, S; Fisher, AB; Manevich, Y; Wei, Z | 1 |
Kito, Y; Sanders, KM; Ward, SM | 1 |
Clarkson, CW; Huang, L; Keyser, BM; Li, M; Taylor, JT; Zhuang, H | 1 |
Hayashi, K; Homma, K; Kanda, T; Kumagai, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S | 1 |
Bieger, D; Ford, C; Mong, K; Tabrizchi, R | 1 |
Badawi, JK; Bross, S; Kamp, S; Kwon, ST; Langbein, S; Li, H | 1 |
Hadama, T; Kaku, T; Lee, TS; Miyamoto, S; Ono, K; Perez-Reyes, E; Takebayashi, S; Uchino, T | 1 |
Cabrera, JA; Hong, F; Hong, Z; Nelson, DP; Olschewski, A; Varghese, A; Weir, EK | 1 |
Black, N; Dhamija, S; Kowala, MC; Liachenko, S; Madore, S; Major, TC; Morenko, B; Okerberg, C; Sobocinski, G; Tinholt, P | 1 |
Ball, CJ; Beltrame, JF; Saint, DA; Turner, SP; Wilson, DP | 1 |
Godfraind, T | 1 |
Cagney, V; Hollywood, M; Large, R; McCloskey, C; McHale, N; Sergeant, G; Thornbury, K | 1 |
Amobi, N; Guillebaud, J; Smith, CH | 1 |
Cao, C; Khurana, S; Lin, H; Pallone, TL; Zhang, Z | 1 |
Cribbs, LL; Hansen, PB; Jensen, BL; Marcussen, N; Poulsen, CB; Skøtt, O; Walter, S | 1 |
Braunstein, TH; Giese, I; Holstein-Rathlou, NH; Salomonsson, M; Sorensen, CM | 1 |
Capuano, V; Ferron, L; Renaud, JF; Ruchon, Y; Sankhe, S | 1 |
Bao, XX; Wang, JL; Wei, LH | 1 |
Stengl, M; Wei, H | 1 |
Dulon, D; Levic, S | 1 |
Akerman, KE; Castrén, ML; Hakala, E; Jansson, LC; Louhivuori, LM; Louhivuori, V; Nordström, T; Wigren, HK | 1 |
Fukunaga, K; Han, F; Moriguchi, S; Shioda, N; Yamamoto, Y | 1 |
Chitaley, K; Jiang, X; Luttrell, I; Yang, CC | 1 |
Lee, S; Roizes, S; von der Weid, PY | 1 |
Cantí, C; Das, A; Herreros, J; Nàger, M; Pamplona, R; Purroy, R; Pushparaj, C | 1 |
Batarfi, M; Jaffer, S; Luke, G; Patel, K; Valasek, P; Whalley, BJ | 1 |
Hashitani, H; Mitsui, R | 1 |
Chuang, JY; Hsu, TI; Kao, TJ; Limanjaya, I | 1 |
Chadjichristos, CE; Chatziantoniou, C; Helle, F; Hultström, M; Iversen, B; Kavvadas, P | 1 |
3 review(s) available for nifedipine and mibefradil
Article | Year |
---|---|
[Calcium channel blocker for therapy of patients with hypertension].
Topics: Benzimidazoles; Calcium Channel Blockers; Dihydropyridines; Drug Interactions; Humans; Hypertension; Mibefradil; Nifedipine; Tetrahydronaphthalenes; Thiazoles | 1997 |
Diversity of calcium antagonists.
Topics: Angina Pectoris; Arteriosclerosis; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Humans; Hypertension; Kidney Failure, Chronic; Mibefradil; Nifedipine; Tetrahydronaphthalenes; Verapamil | 1997 |
Use of calcium channel blockers in hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Case-Control Studies; Clinical Trials as Topic; Dihydropyridines; Diltiazem; Heart Diseases; Humans; Hypertension; Longitudinal Studies; Mibefradil; Nifedipine; Public Health; Randomized Controlled Trials as Topic; Risk Factors; Tetrahydronaphthalenes; Vasodilator Agents; Verapamil | 1998 |
8 trial(s) available for nifedipine and mibefradil
Article | Year |
---|---|
The antihypertensive efficacy of the novel calcium antagonist mibefradil in comparison with nifedipine GITS in moderate to severe hypertensives with ambulatory hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Body Weight; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Mibefradil; Middle Aged; Nifedipine; Tetrahydronaphthalenes | 1997 |
Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
Topics: Adult; Aged; Amlodipine; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Edema; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Leg; Male; Mibefradil; Middle Aged; Nifedipine; Tetrahydronaphthalenes | 1997 |
Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist.
Topics: Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Drug Administration Schedule; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Hypertension; Male; Mibefradil; Middle Aged; Nifedipine; Tetrahydronaphthalenes | 1997 |
Differential properties of mibefradil in hypertension and angina.
Topics: Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Heart Rate; Humans; Hypertension; Mibefradil; Nifedipine; Tetrahydronaphthalenes | 1997 |
A comparison of the safety and efficacy of mibefradil and nifedipine SR in patients with renal disease and hypertension.
Topics: Adult; Aged; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Male; Mibefradil; Middle Aged; Nifedipine; Tetrahydronaphthalenes | 1998 |
Steady-state trough plasma mibefradil concentrations and correlation to blood pressure response in hypertensive patients with chronic renal disease.
Topics: Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypertension; Kidney Failure, Chronic; Linear Models; Mibefradil; Nifedipine; Tetrahydronaphthalenes | 1998 |
Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension.
Topics: Autonomic Nervous System; Calcium Channel Blockers; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Humans; Hypertension; Male; Mibefradil; Middle Aged; Nifedipine; Norepinephrine; Pressoreceptors; Prospective Studies | 2001 |
Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers.
Topics: Administration, Oral; Adult; Aldosterone; Amlodipine; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Electrocardiography; Epinephrine; Hemodynamics; Humans; Male; Mibefradil; Nifedipine; Sympathetic Nervous System | 2001 |
67 other study(ies) available for nifedipine and mibefradil
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
Identification of the first in silico-designed TREK1 antagonists that block channel currents dose dependently.
Topics: Animals; Computer Simulation; Crystallography, X-Ray; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Mice; Mice, Knockout; Molecular Docking Simulation; Potassium Channels, Tandem Pore Domain | 2016 |
Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
Topics: Amlodipine; Animals; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Hemodynamics; Male; Mibefradil; Nifedipine; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Verapamil | 1991 |
[Inhibition of induced contraction in the isolated rat mesenteric vascular bed by Ro 40-5967, a novel calcium antagonist].
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Electric Stimulation; Endothelins; In Vitro Techniques; Male; Mesenteric Arteries; Mibefradil; Nifedipine; Norepinephrine; Rats; Rats, Wistar; Receptors, Endothelin; Tetrahydronaphthalenes; Vasoconstriction; Vasodilator Agents | 1995 |
Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
Topics: Benzimidazoles; Calcium Channel Blockers; Electric Stimulation; Heart Ventricles; Humans; In Vitro Techniques; Mibefradil; Myocardial Contraction; Nifedipine; Papillary Muscles; Tetrahydronaphthalenes; Verapamil | 1997 |
[Introducing mibefradil--a new T-calcium channel blocker].
Topics: Antihypertensive Agents; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Humans; Hypertension; Mibefradil; Nifedipine; Tetrahydronaphthalenes | 1997 |
Different effects of calcium antagonists on fluid filtration of large arteries and albumin permeability in spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Capillary Permeability; Carotid Arteries; Edema; Heart Rate; Hemodynamics; Hypertension; Male; Mibefradil; Nifedipine; Rats; Rats, Inbred SHR; Serum Albumin; Tetrahydronaphthalenes | 1998 |
Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.
Topics: Adult; Aged; Arteries; Benzimidazoles; Calcium; Calcium Channel Blockers; Diltiazem; Fluorescent Dyes; Fura-2; Heart; Humans; Mibefradil; Middle Aged; Myocardium; Nifedipine; Tetrahydronaphthalenes; Vasodilator Agents | 1998 |
Proliferation of human peripheral blood mononuclear cells during calcium channel blockade.
Topics: Adult; Benzimidazoles; Calcium Channel Blockers; Gallic Acid; Humans; Lymphocyte Activation; Male; Mibefradil; Nifedipine; Sulfonamides; Tetrahydronaphthalenes; Time Factors | 1998 |
Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cell Division; Gallic Acid; Humans; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Mibefradil; Nifedipine; Receptors, Interleukin-2; Tetrahydronaphthalenes; Time Factors | 1999 |
Proliferation of human peripheral blood mononuclear cells during calcium entry blockade. Role of protein kinase C.
Topics: Adult; Benzimidazoles; Calcium Channel Blockers; Cell Division; Concanavalin A; DNA; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Leucine; Leukocytes, Mononuclear; Male; Mibefradil; Nifedipine; Protein Kinase C; Pyrimidine Nucleosides; Tetradecanoylphorbol Acetate; Tetrahydronaphthalenes; Thymidine; Uridine | 1999 |
Calcium currents in hair cells isolated from semicircular canals of the frog.
Topics: Animals; Barium; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, R-Type; Hair Cells, Vestibular; In Vitro Techniques; Kinetics; Membrane Potentials; Mibefradil; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Patch-Clamp Techniques; Rana esculenta; Semicircular Canals; Video Recording | 2000 |
Gonadotropin-releasing hormone-stimulated sperm binding to the human zona is mediated by a calcium influx.
Topics: Calcium; Calcium Channel Blockers; Calcium Channels; Diltiazem; Egtazic Acid; Female; Gonadotropin-Releasing Hormone; Humans; Male; Mibefradil; Nifedipine; Pimozide; Sperm-Ovum Interactions; Spermatozoa; Verapamil; Zona Pellucida | 2000 |
Mibefradil, an I(Ca,T) blocker, effectively blocks I(Ca,L) in rabbit sinus node cells.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Female; Mibefradil; Nifedipine; Rabbits; Sinoatrial Node | 2000 |
Acrosome reaction of human spermatozoa is mainly mediated by alpha1H T-type calcium channels.
Topics: Acrosome Reaction; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Cattle; Dose-Response Relationship, Drug; Humans; Male; Mannose; Mibefradil; Nickel; Nifedipine; Protein Isoforms; Protein Subunits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serum Albumin, Bovine; Spermatozoa; Testis | 2000 |
Influence of T-type Ca2+ (mibefradil) and Cl- (indanyloxyacetic acid 94) channel antagonists on alpha1-adrenoceptor mediated contractions in rat aorta.
Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Calcium Channel Blockers; Calcium Channels, T-Type; Chloride Channels; Diuretics; Dose-Response Relationship, Drug; Glycolates; Imidazoles; Male; Mibefradil; Nifedipine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Vasoconstriction | 2000 |
Effects of mibefradil and nifedipine on arteriolar myogenic responsiveness and intracellular Ca(2+).
Topics: Animals; Arterioles; Calcium; Calcium Channel Blockers; Male; Membrane Potentials; Mibefradil; Muscle Tonus; Muscle, Smooth, Vascular; Nifedipine; Potassium; Rats; Rats, Sprague-Dawley | 2000 |
Selectivity of blocking of low- versus high-voltage activated calcium currents by the dihydropyridine derivatives Bay E5759 and Bay A4339 in neuroblastoma--glioma NG 108-15 cells.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Electrophysiology; Hybrid Cells; Mibefradil; Mice; Nifedipine; Nisoldipine; Rats; Tumor Cells, Cultured | 2001 |
Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Male; Mibefradil; Natriuresis; Nifedipine; Nitric Oxide; Nitrophenols; Organophosphorus Compounds; Prostaglandins; Renal Circulation | 2001 |
Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
Topics: Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Hydronephrosis; In Vitro Techniques; Kidney; Male; Mibefradil; Nifedipine; Norepinephrine; Phentolamine; Rats; Rats, Wistar; Renal Artery; Renal Circulation; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Dogs; Hemodynamics; Mibefradil; Microcirculation; Nifedipine; Nitrophenols; Organophosphorus Compounds; Renal Circulation; Vasodilation | 2001 |
Effect of nitric oxide synthase inhibitor N(omega) nitro-L-arginine methyl ester on relaxant responses to calcium channel antagonists in isolated aortic rings from Dahl normotensive and hypertensive rats.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Diltiazem; Enzyme Inhibitors; Female; Hypertension; Imidazoles; In Vitro Techniques; Mibefradil; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide Synthase; Potassium Chloride; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Vasoconstrictor Agents; Vasodilation | 2002 |
Effects of mibefradil on uterine contractility.
Topics: Animals; Calcium Channel Blockers; Calcium Chloride; Drug Interactions; Female; Mibefradil; Nifedipine; Oxytocin; Pregnancy; Rats; Rats, Wistar; Uterine Contraction | 2002 |
Characterization of T-type calcium current and its contribution to electrical activity in rabbit urethra.
Topics: Action Potentials; Animals; Barium; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Electric Conductivity; Female; In Vitro Techniques; Male; Mibefradil; Models, Biological; Nickel; Nifedipine; Patch-Clamp Techniques; Rabbits; Urethra | 2004 |
Depolarization-induced calcium influx in rat mesenteric small arterioles is mediated exclusively via mibefradil-sensitive calcium channels.
Topics: Animals; Arterioles; Blotting, Southern; Calcium; Calcium Channels; Denmark; Elapid Venoms; Fluorescence; Fura-2; Gene Expression; Lanthanum; Male; Membrane Potentials; Mesenteric Arteries; Mibefradil; Muscle, Smooth, Vascular; Nifedipine; omega-Agatoxin IVA; omega-Conotoxins; Phentolamine; Pimozide; Potassium Chloride; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Calcium Exchanger; Solutions; Spider Venoms; Tetrodotoxin | 2004 |
Ca2+ flux through voltage-gated channels with flow cessation in pulmonary microvascular endothelial cells.
Topics: Animals; Blotting, Western; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Capillaries; Cromakalim; Endothelial Cells; Endothelium, Vascular; Ion Channel Gating; Ion Transport; Lung; Membrane Potentials; Mibefradil; Nifedipine; Potassium Channel Blockers; Potassium Channels; Rats; Reverse Transcriptase Polymerase Chain Reaction; Rheology; RNA, Messenger | 2004 |
Pacemaker potentials generated by interstitial cells of Cajal in the murine intestine.
Topics: Animals; Anti-Arrhythmia Agents; Biological Clocks; Caffeine; Calcium Channel Blockers; Central Nervous System Stimulants; Electrophysiology; Glyburide; In Vitro Techniques; Intestine, Small; Membrane Potentials; Mibefradil; Mice; Mice, Inbred BALB C; Myocytes, Smooth Muscle; Nifedipine; Pinacidil; Vasodilator Agents | 2005 |
Role of high-voltage-activated calcium channels in glucose-regulated beta-cell calcium homeostasis and insulin release.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line, Tumor; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mibefradil; Nifedipine; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2005 |
Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney.
Topics: Angiotensin II; Animals; Arterioles; Calcium; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydronephrosis; Hypertension; Kidney; Male; Mibefradil; Microcirculation; Nifedipine; Perfusion; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Staurosporine; Thapsigargin; Vasodilator Agents | 2005 |
Relaxant responses to calcium channel antagonists and potassium channel opener in human saphenous vein.
Topics: Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Membrane Potentials; Mibefradil; Muscle, Smooth, Vascular; Nifedipine; Pinacidil; Potassium Channels; Saphenous Vein; Vasodilation; Vasodilator Agents | 2006 |
Inhibitory effects of L- and T-type calcium antagonists on contractions of human detrusor muscle.
Topics: Adult; Aged; Analysis of Variance; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Carbachol; Diltiazem; Female; Humans; In Vitro Techniques; Male; Mibefradil; Middle Aged; Muscle Contraction; Muscle, Smooth; Nifedipine; Nimodipine; Potassium; Urinary Bladder; Verapamil | 2006 |
Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
Topics: Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Dihydropyridines; Humans; Mibefradil; Nifedipine; Nitrophenols; Organophosphorus Compounds; Recombinant Proteins | 2006 |
Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus.
Topics: Animals; Arachidonic Acids; Boron Compounds; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cytosol; Ductus Arteriosus; Endocannabinoids; Imidazoles; In Vitro Techniques; Indoles; Intracellular Signaling Peptides and Proteins; Isoquinolines; Maleimides; Menthol; Mibefradil; Muscle Contraction; Nifedipine; Niflumic Acid; Oxidation-Reduction; Oxygen; Patch-Clamp Techniques; Polyunsaturated Alkamides; Potassium Channels; Protein Serine-Threonine Kinases; Rabbits; rho-Associated Kinases; Ruthenium Red; Sulfonamides; Tetraethylammonium; Thapsigargin; Thiourea | 2006 |
The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Edema; Femoral Artery; Hindlimb; Hypertension; Magnetic Resonance Imaging; Mibefradil; Muscle, Skeletal; Nifedipine; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA, Messenger | 2008 |
Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
Topics: Animals; Aorta; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Humans; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Mibefradil; Microvessels; Nifedipine; Nitrophenols; Organophosphorus Compounds; Potassium Chloride; Rats; Rats, Sprague-Dawley; Subcutaneous Fat; Vasoconstriction; Verapamil | 2009 |
Is combined L- and T-channel blockade better than L-channel blockade in therapy?
Topics: Animals; Aorta; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Drug Synergism; Humans; Hypertension; Mesenteric Arteries; Mibefradil; Microvessels; Nifedipine; Nitrophenols; Rats; Vasoconstriction; Verapamil | 2009 |
Voltage-dependent Ca2+ currents contribute to spontaneous Ca2+ waves in rabbit corpus cavernosum myocytes.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, T-Type; Cells, Cultured; Dose-Response Relationship, Drug; Male; Mibefradil; Microscopy, Confocal; Muscle Cells; Muscle, Smooth; Nifedipine; Penis; Rabbits; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Comparative effects of T-type and L-type Ca(2+)-antagonists against noradrenaline-induced contractions of human vas deferens.
Topics: Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Flunarizine; Humans; Male; Mibefradil; Muscle Contraction; Muscle, Smooth; Nifedipine; Norepinephrine; Pyrroles; Vas Deferens | 2010 |
Voltage-gated divalent currents in descending vasa recta pericytes.
Topics: Animals; Barium; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Kidney Medulla; Mibefradil; Models, Animal; Nickel; Nifedipine; omega-Agatoxin IVA; Patch-Clamp Techniques; Pericytes; Pyrroles; Rats | 2010 |
Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature.
Topics: Adult; Aged; Aged, 80 and over; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, P-Type; Calcium Channels, Q-Type; Calcium Channels, T-Type; Female; Gene Expression; Humans; Immunohistochemistry; In Vitro Techniques; Kidney; Male; Mibefradil; Mice; Mice, Inbred C57BL; Middle Aged; Muscle, Smooth, Vascular; Nifedipine; omega-Agatoxin IVA; Renal Artery; Reverse Transcriptase Polymerase Chain Reaction; Vasoconstriction | 2011 |
Closure of multiple types of K+ channels is necessary to induce changes in renal vascular resistance in vivo in rats.
Topics: Animals; Arterioles; Benzimidazoles; Calcium Channels; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Mibefradil; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Nifedipine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Renal Circulation; Vascular Resistance; Vasoconstriction | 2011 |
T-type Ca²⁺ signalling downregulates MEK1/2 phosphorylation and cross-talk with the RAAS transcriptional response in cardiac myocytes.
Topics: Animals; Calcium Signaling; Flunarizine; Fluoxetine; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mibefradil; Mifepristone; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Nifedipine; Phosphorylation; Rats; Rats, Wistar; Receptors, Glucocorticoid; Renin-Angiotensin System; Spironolactone | 2012 |
[Impact of calcium channel antagonists for estrogen action on the endometrial carcinoma HEC-1A cells].
Topics: Apoptosis; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Estrogens; Female; Humans; Mibefradil; Nifedipine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2012 |
Ca²⁺-dependent ion channels underlying spontaneous activity in insect circadian pacemaker neurons.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Calcium Channels, P-Type; Calcium Channels, Q-Type; Circadian Clocks; Cockroaches; Cyclic Nucleotide-Gated Cation Channels; Insect Proteins; Large-Conductance Calcium-Activated Potassium Channels; Male; Mibefradil; Neurons; Nifedipine; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Small-Conductance Calcium-Activated Potassium Channels; Sodium Channel Blockers; Tetrodotoxin; Voltage-Gated Sodium Channels | 2012 |
The temporal characteristics of Ca2+ entry through L-type and T-type Ca2+ channels shape exocytosis efficiency in chick auditory hair cells during development.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chick Embryo; Cochlea; Exocytosis; Hair Cells, Auditory; Mibefradil; Neurogenesis; Nifedipine; Synaptic Transmission; Synaptic Vesicles | 2012 |
Role of low voltage activated calcium channels in neuritogenesis and active migration of embryonic neural progenitor cells.
Topics: Animals; Barium; Benzimidazoles; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Differentiation; Cell Movement; Cells, Cultured; Cyclopropanes; Embryonic Stem Cells; Fura-2; Membrane Potentials; Mibefradil; Mice; Microscopy, Confocal; Naphthalenes; Neural Stem Cells; Neurites; Neurons; Nifedipine; Patch-Clamp Techniques; Time-Lapse Imaging | 2013 |
Novel cognitive enhancer ST101 enhances acetylcholine release in mouse dorsal hippocampus through T-type voltage-gated calcium channel stimulation.
Topics: Acetylcholine; Animals; Calcium Channels, T-Type; Cognition; Hippocampus; Indans; Injections, Intraperitoneal; Male; Memory; Mibefradil; Mice; Nifedipine; Spiro Compounds; Stimulation, Chemical | 2013 |
T- and L-type voltage-gated calcium channels: their role in diabetic bladder dysfunction.
Topics: Acetylcholine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Male; Mibefradil; Mice; Mice, Inbred C57BL; Muscle Contraction; Myocytes, Smooth Muscle; Nifedipine; RNA, Messenger; Urinary Bladder; Urinary Bladder Diseases | 2014 |
Distinct roles of L- and T-type voltage-dependent Ca2+ channels in regulation of lymphatic vessel contractile activity.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Diltiazem; Lymphatic Vessels; Male; Membrane Potentials; Mibefradil; Muscle Contraction; Nickel; Nifedipine; Rats; Rats, Sprague-Dawley | 2014 |
Voltage-gated calcium channel blockers deregulate macroautophagy in cardiomyocytes.
Topics: Animals; Animals, Newborn; Autophagy; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Proliferation; Cell Survival; Endoplasmic Reticulum Stress; Gene Expression Regulation; Heart Ventricles; Heat-Shock Proteins; Macrolides; Mibefradil; Microtubule-Associated Proteins; Myocytes, Cardiac; Nifedipine; Rats; Sequestosome-1 Protein; Signal Transduction; Thapsigargin; Unfolded Protein Response | 2015 |
Characterisation of Development and Electrophysiological Mechanisms Underlying Rhythmicity of the Avian Lymph Heart.
Topics: Action Potentials; Animals; Biological Clocks; Calcium Channels, L-Type; Chick Embryo; Electrophysiology; Homeodomain Proteins; In Situ Hybridization; Lymphatic System; Mibefradil; Microelectrodes; Nifedipine; Tetrodotoxin | 2016 |
Properties of synchronous spontaneous Ca
Topics: Animals; Arterioles; Calcium; Calcium Channel Blockers; Calcium Signaling; Chloride Channels; Male; Membrane Potentials; Mibefradil; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nifedipine; Pericytes; Rats; Rats, Wistar; Rectum; Venules | 2017 |
L-selectin activation regulates Rho GTPase activity via Ca
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line; L-Selectin; Ligands; Male; Mibefradil; Nifedipine; Optical Imaging; rac1 GTP-Binding Protein; Rats; rho GTP-Binding Proteins; Sertoli Cells; Signal Transduction; Spermatogenesis; Spermatozoa | 2020 |
Deletion of Notch3 Impairs Contractility of Renal Resistance Vessels Due to Deficient Ca
Topics: Angiotensin II; Animals; Arterioles; Calcium; Calcium Channel Blockers; Gene Deletion; Kidney; Mibefradil; Mice; Mice, Knockout; Nifedipine; Receptor, Notch3; Vascular Resistance | 2022 |